Finance

Lists
Why is 3759 down 2,22%?
Dive Deeper
3759:HKG
Pharmaron Beijing Ord Shs H
26,40 HKD
-2,22%
(-0,60) 1D
16-окт., 16:08:14 GMT+8  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 3759...
Open
27,50 HKD
High
28,28 HKD
Low
24,64 HKD
Mkt. cap
75,60 млд
Avg. vol.
5,53 млн
Volume
10,40 млн
Dividend
0,87%
Quarterly dividend
0,06 HKD
Ex-dividend date
2026-ж., 7-июл.
P/E ratio
23,70
52-wk high
34,86 HKD
52-wk low
14,45 HKD
EPS
1,11 HKD
No. of employees
27 миң
Open
27,50 HKD
High
28,28 HKD
Low
24,64 HKD
Mkt. cap
75,60 млд
Avg. vol.
5,53 млн
Volume
10,40 млн
Dividend
0,87%
Quarterly dividend
0,06 HKD
Ex-dividend date
2026-ж., 7-июл.
P/E ratio
23,70
52-wk high
34,86 HKD
52-wk low
14,45 HKD
EPS
1,11 HKD
No. of employees
27 миң
News stories
From web sources and news partners
About Pharmaron Beijing Ord Shs H
CEOBoliang Lou
Employees27,3 миң
Founded2004-ж., 1-июл.
Headquarters-
SectorHealth care
Last report
2026-ж., 20-авг.
Fiscal period
Q2 2026
- / 0,28 CN¥
Revenue / Est. (CNY)
4,02 млд / 3,98 млд
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
3,64 млд
4,01 млд
3,58 млд
4,02 млд
Cost of goods sold
2,38 млд
2,57 млд
2,42 млд
2,70 млд
Cost of revenue
2,38 млд
2,57 млд
2,42 млд
2,70 млд
Research and development expenses
141,14 млн
184,42 млн
139,77 млн
156,06 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
540,84 млн
553,55 млн
520,12 млн
587,74 млн
Operating expense
744,80 млн
809,09 млн
701,15 млн
782,02 млн
Total operating expenses
3,13 млд
3,38 млд
3,12 млд
3,48 млд
Operating income
519,36 млн
629,52 млн
461,69 млн
538,28 млн
Other non operating income
-37,81 млн
36,17 млн
-48,69 млн
46,54 млн
EBT including unusual items
516,18 млн
583,78 млн
412,76 млн
513,42 млн
EBT excluding unusual items
478,50 млн
626,67 млн
396,21 млн
436,35 млн
Income tax expense
102,94 млн
94,46 млн
102,35 млн
112,13 млн
Effective tax rate
19,94%
16,18%
24,80%
21,84%
Other operating expenses
56,34 млн
34,47 млн
29,75 млн
32,75 млн
Net income
439,52 млн
522,99 млн
335,36 млн
414,83 млн
Net profit margin
12,06%
13,04%
9,37%
10,33%
Earnings per share
0,27
0,33
-
-
Interest and investment income
12,46 млн
9,47 млн
34,76 млн
16,83 млн
Interest expense
-47,49 млн
-51,15 млн
-51,56 млн
-48,40 млн
Net interest expenses
-35,03 млн
-41,68 млн
-16,80 млн
-31,58 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
735,19 млн
881,17 млн
713,34 млн
834,44 млн
Gain or loss from assets sale
-3,36 млн
4,69 млн
-
-5,29 млн
AI content may include mistakes. Learn more
Google колдонмолору